D-0052-2018 Class III Terminated

Recalled by Teva Pharmaceuticals USA — North Wales, PA

FDA drug recall D-0052-2018 was initiated by Teva Pharmaceuticals USA on Oct 17, 2017 and is designated Class III. Reason for recall: Failed Dissolution Specifications: Low out of specification results for dissolution. The recall status is terminated (terminated Apr 12, 2018). Affected quantity: 58,292 bottles.

Recall details

Product Type
Drugs
Report Date
Nov 1, 2017
Initiation Date
Oct 17, 2017
Termination Date
Apr 12, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
58,292 bottles

Product description

Methylphenidate Hydrochloride Tablets USP, 20 mg, 100-count bottles, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880 USA, NDC 0591-5884-01.

Reason for recall

Failed Dissolution Specifications: Low out of specification results for dissolution.

Distribution pattern

Nationwide in the USA and Puerto Rico

Code information

Lot Number # 1156086M, Exp 08/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0052-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0052-2018. Report a data issue: hello@regdatalab.com.